Search results
...WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against...
CBS 47 Fresno· 10 hours agoFoti, Jr., remind investors that they have until June 25, 2024 to file lead plaintiff applications...
Dog food sold by Walmart is recalled because it may contain metal pieces - WDEF
WDEF Chattanooga· 5 days agoAttention Walmart shoppers: bags of dry Pedigree-branded dog food sold by the retailer have been...
FDA lifts hold on Larimar's Friedreich's Ataxia drug study By Investing.com
Investing.com· 4 days agoLarimar Therapeutics, Inc. (NASDAQ:LRMR), a biotechnology firm engaged in developing treatments for...
Biogen to acquire privately held Human Immunology Biosciences for $1.15 billion upfront
Market Watch· 3 days agoBiogen Inc. said Wednesday it’s acquiring privately held Human Immunology Biosciences for $1.15...
Exclusive | Elon Musk’s Neuralink Gets FDA Green Light for Second Patient, as First Describes His...
The Wall Street Journal· 5 days agoThe U.S. Food and Drug Administration gave a green light to Elon Musk’s Neuralink to implant its...
Lipella Pharmaceuticals advances hemorrhagic cystitis treatment By Investing.com
Investing.com· 4 days agoLipella Pharmaceuticals Inc. (NASDAQ: LIPO), a clinical-stage biotech firm, announced today its...
...Bristol Myers Squibb Received Updated Action Date from the U.S. Food and Drug Administration for...
FOX 23 News Albany· 4 days agoHalozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Bristol Myers Squibb was reassigned a Prescription Drug User Fee Act goal date from the
ENDRA meets with FDA on liver device clinical trial design By Investing.com
Investing.com· 5 days agoENDRA Life Sciences Inc. (NASDAQ: NASDAQ:NDRA), a developer of Thermo Acoustic Enhanced UltraSound...
FDA sets new review date for Halozyme's drug delivery tech By Investing.com
Investing.com· 4 days agoHalozyme (NASDAQ:HALO) Therapeutics, Inc. (NASDAQ: HALO) announced that the U.S. Food and Drug...
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF...
WKRN Nashville· 5 days agoCantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions ...